ID guidelines Microbes VIRUSES influenza (IDSA 2018) Hepatitis C (AASLD/IDSA website) Hepatitis B (AASLD 2018) Hepatitis B Reactivation During Immunosuppressive Therapy (AGA 2015) HIV (Adult): Primary Care (HIVMA/IDSA 2020) Antiretroviral Agents (NIH/HHS) Prevention and Treatment of OI (NIH/HHS) Chronic Pain Management (HIVMA/IDSA 2017) Chronic Kidney Disease (HIVMA/IDSA 2014) Primary Care (HIVMA/IDSA 2013) (archived) HIV (Pediatric): Antiretroviral Agents (NIH/HHS) Prevention and Treatment of OI (NIH/HHS) HIV Perinatal (NIH/HHS) spirochetes Lyme Disease (IDSA 2020) Babesiosis (IDSA 2020) Lyme Disease, Anaplasmosis, Babesiosis (IDSA 2006) (archived) mycobacteria TB: Latent Tb Treatment (CDC/Tuberculosis Controllers Association 2020) Drug-resistant Tuberculosis Treatment (ATS/CDC/ERS/IDSA 2019) Tuberculosis Diagnosis (ATS/IDSA/CDC 2016) Tuberculosis Treatment (ATS/CDC/IDSA 2016) Controlling Tuberculosis in the United States (ATS/CDC/IDSA 2005) NTM: Nontuberculous Mycobacterial Pulmonary Disease (ATS/ERS/ESCMID/IDSA 2020) Nontuberculous Mycobacterial Diseases (ATS/IDSA 2007) NTM Pulmonary Disease (British Thoracic Society 2017) Bacteria Clostridium difficile focused update (IDSA 2021) Treatment of resistant GNR (AmpC, CRAB, Stenotrophomonas) (IDSA 2021) Treatment of resistant GNR (ESBL, CRE, Pseudomonas) (IDSA 2021) Clostridium difficile (IDSA 2017) Helicobacter pylori (ACG 2017) MRSA (IDSA 2010) (archived) fungi Yeasts: Candidiasis (IDSA 2016) Cryptococcal disease (IDSA 2010) (archived) Dimorphic fungi / Endemic mycoses: Coccidioidomycosis (IDSA 2016) Blastomycosis (IDSA 2008) (archived) Sporotrichosis (IDSA 2007) (archived) Histoplasmosis (IDSA 2007) (archived) Molds: Mucormycosis (European Confederation of Medical Mycology & Mycoses Study Group 2019) Aspergillosis (IDSA 2016) protozoa Malaria Treatment (CDC) Leishmaniasis (IDSA / ASTMH 2016) Helminth neurocysticercosis (IDSA / ASTMH 2017)